My opponent's right that biotech can boost crop yields and help hospitals, and I won't pretend otherwise. But easier for whom? Scaling a biotech fix usually means new dependencies: specialized seeds, cold chains, patents, monitoring, and regulations. A farmer or clinic doesn't just get simplicity; they inherit a system they can't repair themselves. That's the startup trap: you ship a clever solution, then spend years managing the complexity you created. So sure, it makes some tasks easier in the demo, but in the real world it often trades one problem for a more fragile, expensive set of them.